Efficacy and safety of recombinant human endostatin combined with whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer-Reference-Cited by-同舟云学术

Efficacy and safety of recombinant human endostatin combined with whole-brain radiation therapy in patients with brain metastases from non-small cell lung cancer

Published:2022-09 Issue: Volume:174 Page:44-51
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Chen Lingjuan,Tong Fang,Peng Ling,Huang Yu,Yin Ping,Feng Yue,Cheng Shishi,Wang Jing,Dong Xiaorong

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference47 articles.

1. Survival in patients with brain metastases: Summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient;Sperduto;J Clin Oncol,2020

2. Estimating survival in patients with lung cancer and brain metastases: An update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA);Sperduto;JAMA Oncol,2017

3. Stereotactic radiosurgery in the management of limited (1–4) brain metasteses: Systematic review and international stereotactic radiosurgery society practice guideline;Chao;Neurosurgery,2018

4. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline;Tsao;Pract Radiat Oncol,2012

5. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial;Chang;Lancet Oncol,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances progress of targeted drugs combined with radiotherapy for advanced non-small cell lung cancer: a review;Frontiers in Oncology;2023-12-05

2. Nanomedicine Combats Drug Resistance in Lung Cancer;Advanced Materials;2023-11-27

3. Current status and future of anti-angiogenic drugs in lung cancer;Clinical and Experimental Medicine;2023-03-15

4. Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies;Biomedicines;2023-02-27

5. Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer;Pharmaceuticals;2023-01-31